3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
13
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Fatigue
4
Breast Neoplasms
2
Vomiting
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Sleep Wake Disorders
1
Sarcoma
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Complications
1
Pain
1
Nausea
1
Lung Neoplasms
1
Leukemia
1
Infections
1
Endometrial Stromal Tumors
1
Endometrial Neoplasms
1
Depression
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Brain Neoplasms
1
Anxiety Disorders
1
Adenocarcinoma of Lung
1
Interventions
Fluorouracil
29
Leucovorin
26
Oxaliplatin
25
Capecitabine
16
Irinotecan
14
Cetuximab
10
Bevacizumab
9
Radiotherapy
8
Panitumumab
5
Folfox protocol
5
Surgical Procedures, Operative
3
Levamisole
3
Celecoxib
3
tremelimumab
2
neratinib
2
napabucasin
2
durvalumab
2
cediranib
2
aflibercept
2
X-Rays
2
Tegafur
2
Radiofrequency Ablation
2
Psychiatric Rehabilitation
2
Preoperative Exercise
2
Octreotide
2
Mitomycin
2
Interviews as Topic
2
Immunoglobulin G
2
Folic Acid
2
Floxuridine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Colorectal Neoplasms
×
Therapeutics
×
Clear all
NCT00819208
2026-04-24
CHALLENGE
Canadian Cancer Trials Group
Phase NA
Completed
889 enrolled
9 charts